Acute-phase glucose fluctuation is negatively correlated with myocardial salvage after acute myocardial infarction - Involvement of monocyte subsets -

Circulation Journal

Volumn 78, Issue 1, 2014, Pages 170-179

  Teraguchi, Ikuko ^a   Imanishi, Toshio ^a   Ozaki, Yuichi ^a   Tanimoto, Takashi ^a   Ueyama, Minoru ^a   Orii, Makoto ^a   Shiono, Yasutsugu ^a   Shimamura, Kunihiro ^a   Ishibashi, Kohei ^a   Yamano, Takashi ^a   Ino, Yasushi ^a   Yamaguchi, Tomoyuki ^a   Hirata, Kumiko ^a   Kubo, Takashi ^a   Sanke, Tokio ^b   Akasaka, Takashi ^a  

^a Fuchu Hospital   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Glucagon like peptide 1; Glucose fluctuation; Monocyte; Myocardial salvage

Indexed keywords

8 ISOPROSTANE; FLUORESCEIN ISOTHIOCYANATE; GADOLINIUM; GLUCAGON LIKE PEPTIDE 1; GLYCOSYLATED HEMOGLOBIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEART MUSCLE SALVAGE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NUCLEAR MAGNETIC RESONANCE IMAGING;

AGED; ANTIGENS, CD14; BLOOD GLUCOSE; FEMALE; FLOW CYTOMETRY; GLUCAGON-LIKE PEPTIDE 1; GPI-LINKED PROTEINS; HUMANS; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; RECEPTORS, IGG; TIME FACTORS;

EID: 84891066364     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0723     Document Type: Article

References (36)

1. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22: 1827-1831.
2. Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003; 89: 512-516.
3. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: 1748-1754.
4. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000; 321: 405-412.
5. Ishihara M, Kojima S, Sakamoto T, Kimura K, Kosuge M, Asada Y, et al. Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Comparison of blood glucose values on admission for acute myocardial infarction in patients with versus without diabetes mellitus. Am J Cardiol 2009; 104: 769-774.
6. Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Kitabata H, Ino Y, et al. Impact of stress hyperglycemia on myocardial salvage following successfully recanalized primary acute myocardial infarction. Circ J 2012; 76: 2690-2696.
7. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
8. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
9. Gordon S. Macrophage heterogeneity and tissue lipids. J Clin Invest 2007; 117: 89-93.
10. Tsujioka H, Imanishi T, Ikejima H, Kuroi A, Takarada S, Tanimoto T, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol 2009; 54: 130-138.
11. Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Orii M, Shiono Y, et al. Impact of Glucose Fluctuation and Monocyte Subsets on Coronary Plaque Rupture. Nutrition, Metabolism and Cardiovascular Disease. 2013 (in press).
12. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor EF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644-655.
13. - monocytes and microvascular obstruction in ST-segment elevation acute myocardial infarction. Circ J 2010; 74: 1175-1182.
14. Kuroi A, Imanishi T, Suzuki H, Ikejima H, Tsujioka H, Yoshikawa N, et al. Clinical characteristics of patients with Kawasaki disease and levels of peripheral endothelial progenitor cells and blood monocyte subpopulations. Circ J 2010; 74: 2720-2725.
15. + monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris. Circ J 2012; 76: 2412-2418.
16. Ziegler-Heitbrock L, Ancuta P, Crowe S, Marc D, Veronika G, Derek NH, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116: e74-e80.
17. Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004; 109: 2411-2416.
18. Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J. Quantification of myocardial area at risk with T2-weighted CMR. JACC Cardiovasc Imag 2009; 7: 825-831.
19. Friedrich MG, Abedel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008; 51: 1581-1587.
20. Lee S, Tabe D, Nohtom K, Takada M, Morita R, Seino Y, et al. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes. Endocrine J 2010; 57: 119-126.
21. Ceriello A, Zarich SW, Testa R. Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. J Am Coll Cardiol 2009; 53: S9-S13.
22. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355: 773-778.
23. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J 2003; 146: 674-678.
24. Kakio T, Matsumori A, Ono K, Ito H, Matsushima K, Sasayama S. Roles and relationship of macrophage and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart. Lab Invest 2000; 80: 1127-1136.
25. Hayashidani S, Tsutsi H, Shiomi T, Ikeuchi M, Matsusaka H, Suemats N, et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2003; 108: 2134-2140.
26. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, et al. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 2005; 96: 881-889.
27. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57: 1349-1354.
28. Basu S. Metabolism of 8-iso-prostaglandin F2α. FEBS Lett 1998; 428: 32-36.
29. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
30. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Citola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002; 106: 2067-2072.
31. Ndrepepa G, Mehilli J, Schwaiger M, Schuhlen H, Nekolla S, Martinoff S, et al. Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. J Nucl Med 2004; 45: 725-729.
32. Eitel I, Desch S, Fuernau G, Hildebrand L, Gutberlet M, Schuler G, et al. Prognostic significance and determinants of myocardial salvage by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010; 55: 2470-2479.
33. Kishimoto M, Noda M. A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers. Cardiovasc Diabetol 2011; 10: 115.
34. Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes. Ann Intern Med 2005; 143: 559-569.
35. Nikolaidis LA, Mankad S, Sokos GG, Miske G, Shah A, Elahi D, et al. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation 2004; 109: 962-965.
36. Botker HE, Kaltoft AK, Pedersen SF, Kim WY. Measuring myocardial salvage. Cardiovasc Res 2012; 94: 266-275.